blockade therapy to treat active scleroderma renal crisis in pregnancy, because the risk of maternal or fetal death with untreated disease is higher than the risk associated with use of these medications during pregnancy. While scleroderma renal crisis is rare in pregnancy (an estimated 2% of scleroderma pregnancies), it can easily be confused Recommendations and good practice statements (GPS) for pregnancy counseling, assessment, and management in women with rheumatic and musculoskeletal